Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
US: A Call for Improved HIV-Related Scientific Literacy on the Front Lines

Poor scientific literacy among non-medical members of the HIV-related workforce must be addressed in order to better fight the epidemic. Many workers are unfamiliar with biomedical prevention of HIV—using antiretrovirals to reduce the risk of HIV transmission—and don’t know enough about how and when such an intervention should be used.

Published
10 February 2015
From
AIDSMeds
More African Americans still die of HIV than whites and Latinos combined, CDC says

More African Americans still die of HIV than whites and Latinos combined, the Centers for Disease Control and Prevention reported Thursday, but the black death rate is generally declining more quickly than it is for those other groups.

Published
09 February 2015
From
Washington Post
Aids denialism in London – It is really 2015?

The latest in a 30-year long effort to mislead the public was an event in London earlier this month. The Frontline Club – a charitable foundation supporting journalism around the world – chose to lend its venue and name to the promotion of a 16-year old, long discredited book by Joan Shelton questioning the proven link between HIV and AIDS.

Published
09 February 2015
From
Incidence 0
VOICE trial: Microbicide gel may have stopped two out of three HIV infections – in the women who used it

The final published paper on the VOICE trial in women in three African countries mainly reinforces what conference presentations have already shown: this ambitious trial failed to

Published
09 February 2015
By
Gus Cairns
CytoDyn Concludes Phase 2b Study With 98% Success With 4 Weeks of Monotherapy

CytoDyn Inc. (OTCQB:CYDY), a biotechnology company focused on the development of new therapies for combating infection with human immunodeficiency virus (HIV), today announced that it had concluded its Phase 2b treatment substitution study and reported 39 patients out of 40 participating in the study passed 4 weeks of monotherapy with PRO 140.

Published
05 February 2015
From
CytoDyn press release
Researchers identify key mechanisms underlying HIV-associated cognitive disorders

New findings, published today by researchers at the University of California, San Diego School of Medicine, open the door to the development of new therapies to block or decrease cognitive decline due to HIV-associated neurocognitive disorders, estimated to affect 10 to 50 percent of aging HIV sufferers to some degree.

Published
04 February 2015
From
Medical Xpress
No improvements in CD4 count at diagnosis in African patients in last decade

A study by Harvard Medical School has found that the average CD4 count in sub-Saharan African people who are diagnosed with HIV has not risen since 2002.

Published
04 February 2015
By
Gus Cairns
Screening for bone fracture risk should be routine for over-40s with HIV, new guidelines recommend

Screening for fracture risk should be a routine part of HIV care for all over-40s, and all postmenopausal women, all men over 50 and people at

Published
02 February 2015
By
Keith Alcorn
Treatment of the First HIV Positive Patient in ABIVAX's Phase IIa Clinical Trial With ABX464

ABX464 inhibits the biogenesis of viral RNA required for the replication of the HIV virus, a mechanism of action never before explored. ABX464 could be administered less frequently and for shorter periods than current HIV treatments due to its long lasting impact on viral load

Published
02 February 2015
From
ABIVAX press release
PREZCOBIX™ (darunavir/cobicistat) approved in the U.S. for the treatment of adults living with HIV-1

Combined fixed-dose tablet of darunavir and cobicistat can help reduce number of pills in a combination antiretroviral treatment regimen.

Published
30 January 2015
From
Janssen press release

Filter by country